Vitamin D and multiple sclerosis: what are the guidelines for a reliable clinical trial?

References

• Szodoray P, Nakken B, Gaal J et al. The complex role of vitamin D in autoimmune diseases. Scand. J. Immunol.68, 261–269 (2008).
   PubMed Web of Science ®Google Scholar
• Fernandes de Abreu DA, Eyles D, Féron F. Vitamin D, a neuro-immunomodulator: implications for brain and autoimmune diseases. Psychoneuroendocrinology34, 265–277 (2009).
   PubMedGoogle Scholar
• Smolders J, Peelen E, Thewissen M et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun. Rev.8(7), 621–626 (2009).
   PubMed Web of Science ®Google Scholar
• Jensen CJ, Stankovich J, Van der Walt A et al. Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. PLoS One5(4), E10003 (2010).
   PubMedGoogle Scholar
• Ramagopalan SV, Maugeri NJ, Handunnetthi L et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet.5(2), e1000369 (2009).
   PubMed Web of Science ®Google Scholar
• Chen WC, Vayuvegula B, Gupta S. 1,25-dihydroxyvitamin D3-mediated inhibition of human B cell differentiation. Clin. Exp. Immunol.69(3), 639–646 (1987).
   PubMed Web of Science ®Google Scholar
• Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain132(Pt 5), 1146–1160 (2009).
   PubMed Web of Science ®Google Scholar
• Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest.87(3), 1103–1107 (1991).
   PubMed Web of Science ®Google Scholar
• Nataf S, Garcion E, Darcy F et al. 1,25 dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J. Neuropathol. Exp. Neurol.55, 904–914 (1996).
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl Acad. Sci. USA93, 7861–7864 (1996).
   PubMed Web of Science ®Google Scholar
• Agranoff BW, Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet2, 1061–1066 (1974).
   PubMed Web of Science ®Google Scholar
• Smolders J, Thewissen M, Peelen E et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One4(8), e6635 (2009).
   PubMed Web of Science ®Google Scholar
• Munger KL, Levin LI, Hollis BW et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA296, 2832–2838 (2006).
   PubMed Web of Science ®Google Scholar
• Nashold FE, Spach KM, Spanier JA et al. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J. Immunol.83(6), 3672–3681 (2009).
   Google Scholar
• Kragt J, van Amerongen B, Killestein J et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult. Scler.15(1), 9–15 (2009).
   PubMed Web of Science ®Google Scholar
• Smolders J, Menheere P, Kessels A et al. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult. Scler.14(9), 1220–1224 (2008).
   PubMed Web of Science ®Google Scholar
• Mowry EM, Krupp LB, Milazzo M et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann. Neurol.67, 618–624 (2010).
   PubMed Web of Science ®Google Scholar
• van der Mei IA, Ponsonby AL, Dwyer T et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis, case–control study. BMJ327 (7410), 316 (2003).
   PubMed Web of Science ®Google Scholar
• Kampman MT, Wilsgaard T, Mellgren SI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J. Neurol.254, 471–477 (2007).
   PubMed Web of Science ®Google Scholar
• Woolmore JA, Stone M, Pye EM et al. Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. Mult. Scler.13, 369–375 (2007).
   PubMed Web of Science ®Google Scholar
• Garcion E, Sindji L, Nataf S et al. Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol.105, 438–448 (2003).
   PubMed Web of Science ®Google Scholar
• Fernandes de Abreu DA, Ibrahim EC, Boucraut J et al. Severity of experimental autoimmune encephalomyelitis is unexpectedly reduced in mice born to vitamin D-deficient mothers. J. Steroid Biochem. Mol. Biol.121(1–2), 250–253 (2010).
   PubMed Web of Science ®Google Scholar
• Becklund BR, Severson KS, Vang SV et al. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc. Natl Acad. Sci. USA107(14), 6418–6423 (2010).
   PubMed Web of Science ®Google Scholar
• Goldberg P, Fleming MC, Picard EH. Multiple sclerosis, decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med. Hypotheses21, 193–200 (1986).
   PubMed Web of Science ®Google Scholar
• Nordvik I, Myhr KM, Nyland H et al. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol. Scand.102, 143–149 (2000).
   PubMed Web of Science ®Google Scholar
• Kimball SM, Ursell MR, O’Connor P et al. Safety of vitamin D3 in adults with multiple sclerosis. Am. J. Clin. Nutr.86, 645–651 (2007).
   PubMed Web of Science ®Google Scholar
• Burton JM, Kimball S, Vieth R et al. A Phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology74(23), 1852–1859 (2010).
   PubMed Web of Science ®Google Scholar